Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nature Medicine|June 13, 2018
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockadeDaniela S Thommen, Viktor H Koelzer, Petra Herzig, et al.
Cancer Research Communications|May 13, 2026
Early ctDNA dynamics predict response to mosperafenib in BRAF V600-mutant metastatic colorectal cancerMartha Liliana Serrano-Serrano, Christina Godfried Sie, Oliver Bechter, et al.
Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.
Blood|June 25, 2013
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domainSimona Soverini, Caterina De Benedittis, K Machova Polakova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid TumorsMaria Vieito, Elisa Fontana, Catherine H Han, et al.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Frontiers in Immunology|May 4, 2026
Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an in vitro-based safety approachAngelique Augustin, Blandine Avignon, Christophe Boetsch, et al.
Pageof 3